Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · IEX Real-Time Price · USD
2.080
-0.010 (-0.48%)
Jul 22, 2024, 10:03 AM EDT - Market open
Cardiol Therapeutics Employees
Cardiol Therapeutics had 6 employees as of December 31, 2018.
Employees
6
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$5,036,431
Market Cap
144.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2018 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InfuSystem Holdings | 516 |
| ProQR Therapeutics | 157 |
| Zomedica | 144 |
| Myomo | 106 |
| EUDA Health Holdings | 106 |
| Vigil Neuroscience | 69 |
| Elevation Oncology | 29 |
| PDS Biotechnology | 25 |
CRDL News
- 24 days ago - Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders - Newsfile Corp
- 27 days ago - Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT - Newsfile Corp
- 5 weeks ago - Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024 - Newsfile Corp
- 3 months ago - Cardiol Therapeutics Announces Year-End 2023 Update on Operations - Newsfile Corp
- 5 months ago - Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis - Newsfile Corp
- 5 months ago - Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis - Newsfile Corp
- 6 months ago - Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market - Newsfile Corp